Intravenous amiodarone for conversion of atrial fibrillation: Misled by meta-analysis?

Pharmacotherapy

Volumn 24, Issue 6, 2004, Pages 792-798

  Slavik, Richard S ^a,b   Zed, Peter J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

Amiodarone; Anti arrhythmia agents; Atrial fibrillation; Cardioversion; Meta analysis

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT;

ACCURACY; CLINICAL TRIAL; CONSENSUS; DATA ANALYSIS; EVIDENCE BASED MEDICINE; HEART ATRIUM FIBRILLATION; HEART VENTRICLE; HUMAN; HYPOTHESIS; INTERNATIONAL COOPERATION; META ANALYSIS; METHODOLOGY; PATIENT SELECTION; PRACTICE GUIDELINE; REVIEW; SINUS RHYTHM; STROKE; SYSTEMATIC REVIEW; VALIDATION PROCESS;

ADMINISTRATION, ORAL; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ELECTRIC COUNTERSHOCK; HEART RATE; HUMANS; INFUSIONS, INTRAVENOUS; META-ANALYSIS; TREATMENT OUTCOME;

EID: 2942554867     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.24.8.792.36065     Document Type: Review

References (21)

1. Lee JK, Klein GJ, Krahn AD, et al. Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study. Am Heart J 2000;140:871-7.
2. Hohnloser SH, Kuck KH, Lilienthal J, for the Pharmacological Intervention in Atrial Fibrillation Investigators. Rhythm or rate control in atrial fibrillation-pharmacological intervention in atrial fibrillation (PIAF): a randomized trial. Lancet 2000;356:1789-94.
3. Van Gelder IC, Hagens VE, Bosker HA, et al, for the Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002;347:1834-40.
4. The Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-33.
5. The American Heart Association in Collaboration with the International Liaison Committee on Resuscitation (ILCOR). Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care: international consensus on science. Circulation 2000;102:11-384.
6. Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. J Am Coll Cardiol 2001;38:1231-65.
7. Prystowsky EN, Benson DW Jr, Fuster V, et al. Management of patients with atrial fibrillation: a statement for healthcare professionals from the subcommittee on electrocardiography and electrophysiology: American Heart Association. Circulation 1996;93:1262-77.
8. Chow MSS. Intravenous amiodarone: pharmacology, pharmacokinetics, and clinical use. Ann Pharmacother 1996;30:637-43.
9. Slavik RS, Tisdale JE, Borzak S. Pharmacologic conversion of atrial fibrillation: a systematic review of available evidence. Prog Cardiovasc Dis 2001;44:121-52.
10. Slavik RS. Intravenous amiodarone for acute pharmacological conversion of atrial fibrillation in the emergency department. Can J Emerg Med 2002;4:414-20.
11. Letelier LM, Udol K, Ena J, Weaver B, Guyatt G. Effectiveness of amiodarone for conversion of atrial fibrillation to sinus rhythm: a meta-analysis. Arch Intern Med 2003;163:777-85.
12. Cybulski J, Kulakowski P, Budaj A, et al. Intravenous amiodarone for cardioversion of recent-onset atrial fibrillation. Clin Cardiol 2003;26:329-35.
13. Thomas SP, Guy D, Wallace E, et al. Rapid loading of sotalol or amiodarone for management of recent onset symptomatic atrial fibrillation: a randomized digoxin-controlled trial [online exclusive article]. Am Heart J 2004;147:e3. Available from www.mosby.comahj. Accessed April 5, 2004.
14. Miller MR, McNamara RL, Segal JB, et al. Efficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm: a meta-analysis of clinical trials. J Fam Pract 2000;49:1033-46.
15. Hilleman DE, Spinler SA, Conversion of recent-onset atrial fibrillation with intravenous amiodarone: a meta-analysis of randomized controlled trials. Pharmacotherapy 2002;22:66-74.
16. Chevalier P, Durand-Dubief A, Burri H, Cucherat M, Kirkorian G, Touboul P. Amiodarone versus placebo and class Ic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis. J Am Coll Cardiol 2003;41:255-62.
17. Albers GW, Dalen JE, Laupacis A, Manning WJ, Petersen P, Singer DE. Antithrombotic therapy in atrial fibrillation. Chest 2001;119:194S-204.
18. Wellens HJJ, Brugada P, Abdollah H, Dassen WR. A comparison of the electrophysiologic effects of intravenous and oral amiodarone in the same patient. Circulation 1984;69: 120-4.
19. Zhou L, Chow MSS, Chen BP, Fan C, Kluger J. Electrophysiologic and antifibrillatory effects of amiodarone and desethylamiodarone [abstr]. J Am Coll Cardiol 1997;29:34A.
20. Maisel WH, Rawn JD, Stevenson WG. Atrial fibrillation after cardiac surgery. Ann Intern Med 2001;135:1061-73.
21. Cohen HE, ed. Drug topics red book. Montvale, NJ: Medical Economics, Co., 2003.